The Peritoneal Membrane—A Potential Mediator of Fibrosis and Inflammation among Heart Failure Patients on Peritoneal Dialysis
Peritoneal dialysis is a feasible, cost-effective, home-based treatment of renal replacement therapy, based on the dialytic properties of the peritoneal membrane. As compared with hemodialysis, peritoneal dialysis is cheaper, survival rate is similar, residual kidney function is better preserved, fl...
Egile Nagusiak: | Margarita Kunin, Pazit Beckerman |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
MDPI AG
2022-03-01
|
Saila: | Membranes |
Gaiak: | |
Sarrera elektronikoa: | https://www.mdpi.com/2077-0375/12/3/318 |
Antzeko izenburuak
-
Peritoneal dialysis in congestive heart failure
nork: Abirami Krishnan, et al.
Argitaratua: (2017-04-01) -
Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis: A case series
nork: Margarita Kunin, et al.
Argitaratua: (2018-01-01) -
Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis: A case series
nork: Margarita Kunin, et al.
Argitaratua: (2018-01-01) -
Optimal peritoneal fluid white blood cell count for diagnosis of peritonitis in peritoneal dialysis patients
nork: Margarita Kunin, et al.
Argitaratua: (2023-01-01) -
Peritoneal dialysis in patients with refractory congestive heart failure
nork: Raymond Azar, et al.
Argitaratua: (2022-04-01)